![]() We specialize in molecular testing and Point of Care immunoassay.Īt Accel Diagnostics our mission is to transform the way a wide variety of medical conditions are monitored and diagnosed on-site, in a patient’s home, doctor's office, and at a patient’s bedside. After year of research and a multimillion dollar investment we have created the ADX Cards™. ![]() We are a CLIA high complexity laboratory and a developer and manufacturer of blood diagnostic tests. Our Mission BETTER DIAGNOSTICS TO EMPOWER A MODERN HEALTH CARE SYSTEM Since then, Accel Diagnostics has invested many years and millions of dollars in R&D activities to further develop, refine, and perfect this technology. The ADX technology was first developed at the Biomedical Engineering Department at Carnegie Mellon University and was subsequently licensed to Accel Diagnostics. The test results will be stored on an encrypted cloud server, and users will be able to share the results with a simple click. The change in flow is proportional to the concentration and size of aggregates, which is proportional to the concentration of the targeted biomolecules. The test result is read directly on the test card’s scale - as easy as reading a thermometer - or by scanning the test card with a smartphone. ![]() A tiny magnet captures the magnetic aggregates, which in turn alters the flow of the liquid sample inside of the microfluidic chip. Under the capillary driven flow, the aggregates grow in size, amplifying the signal. The ADX Test Cards are made of a single-use microfluidic chip where millions of micron-size magnetic beads recognize and specifically bind to (and only to) the targeted biomolecules. When liquid sample enters the card, these biomolecules induce the formation of bead aggregates. Results are ready in less than 10 minutes Single-use, fully disposable, and as compact as a credit cardĪccurate and sensitive readings, matching lab performances The ADX™ Technology transforms the patient blood testing paradigm, from lab-centered to near-patient, bringing significant advantages in terms of simplicity, testing time, care delivery, and cost over current standard lab-based diagnostics.Critical tests to aid and guide the doctor's decision-making can now be completed anywhere-anytime, at the patient’s side. Results compare for sensitivity to laboratory devices. It works with many liquids including whole blood, plasma, serum, and mediums. It only requires a few micro-liters of sample (equivalent to 1 - 3 drops). In simple term, this means that the entire test fits in a disposable, credit card sized, self-contained chip without compromising test accuracy.The results are comparable for sensitivity to standard laboratory-based devices. The Accel Diagnostics ADX POC assays are reader-free mobile-enable blood diagnostic tests. It is a single-use, fully integrated, molecular assay for the quantification of biomolecules in a simple to use, disposable format without the needing complex and expansive readers. The ADX™ Technology is a novel microfluidic platform. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |